BridgeBio Pharma BBIO
NASDAQ BBIO
$66.63 +0.66 (+1.00%)
As of: Sep 30, 2026 · 11:31 AM EDT

BridgeBio Pharma (BBIO) Accounts Payables (2018 - 2026)

Updated

BridgeBio Pharma's Accounts Payables came in at $27.2 million for Q2 2026, up 4.1% from $26.13 million a year earlier but down 6.4% from the prior quarter.

Analysis

BridgeBio Pharma (BBIO) Accounts Payables (2018 - 2026) Analysis & Trends

At the end of FY2025, BridgeBio Pharma's Accounts Payables was $36.23 million, up 276.7% from FY2024.

  • Accounts Payables carries a five-year compound annual growth rate of 32.3% (FY2020 to FY2025).
  • Going back by year, Accounts Payables was $9.62 million in FY2024 (-9.7%), $10.66 million in FY2023 (-7.8%), $11.56 million in FY2022 (-2.7%) and $11.88 million in FY2021 (+32.9%).
  • The five-year range for quarterly Accounts Payables is $3.87 million (Q2 2023) to $36.23 million (Q4 2025).
  • Year-over-year, Accounts Payables has increased for six consecutive quarters, with growth averaging 130.2% over the last eight quarters.
  • The fastest year-over-year change in Accounts Payables over five years came in Q1 2025 (growth of 482.2%), and the weakest in Q2 2022 (a decline of 60.6%).
  • Business Quant data shows BBIO's Accounts Payables at $29.06 million (Q1 2026), $36.23 million (Q4 2025) and $18.7 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 9.22 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 33.30 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -22.89 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 674.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 429.50 Mn
10 BridgeBio Pharma 13.01 Bn 10.12 Bn 228.63 Mn 27.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 27.20 Mn
Mar 31, 2026 29.06 Mn
Dec 31, 2025 36.23 Mn
Sep 30, 2025 18.70 Mn
Jun 30, 2025 26.13 Mn
Mar 31, 2025 27.53 Mn
Dec 31, 2024 9.62 Mn
Sep 30, 2024 13.36 Mn
Jun 30, 2024 18.13 Mn
Mar 31, 2024 4.73 Mn
Dec 31, 2023 10.66 Mn
Sep 30, 2023 4.47 Mn
Jun 30, 2023 3.87 Mn
Mar 31, 2023 4.08 Mn
Dec 31, 2022 11.56 Mn
Sep 30, 2022 10.16 Mn
Jun 30, 2022 8.79 Mn
Mar 31, 2022 10.11 Mn
Dec 31, 2021 11.88 Mn
Sep 30, 2021 12.04 Mn
API Access

BridgeBio Pharma Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=BBIO&period=max&api_key=YOUR_API_KEY